Drug-Induced Seizures:A 10-Year Experience
Neurol 34:1582-1586, Messing,R.O.,et al, 1984
Brain Zaps: An Underappreciated Symptom of Antidepressant Discontinuation
Psychiatry.com 2018, Papp, A. & Onton, J.A., 2018
Disorders of the Nervous System Caused by Drugs, Toxins, and Chemical Agents, Monoamine Oxidase Inhibitors
Adams & Victors Principles of Neurology Chp 43, pg 1210, Ropper, A.H.,et al, 2014
Disorders of the Nervous System Caused by Drugs, Toxins, and Chemical Agents, Tricyclic Antidepressants
Adams & Victors Principles of Neurology Chp 43, pg 1211, Ropper, A.H.,et al, 2014
Chronic Daily Headache
NEJM 354:158-165, Dodick,D.W., 2006
The Serotonin Syndrome
NEMJ 352:1112-20, Boyer, E.W. & Shannon, M., 2005
Serotonin Syndrome Induced by Transitioning from Phenelzine to Venlafaxine:four Patient Reports
Neurol 51:274-276, Diamond,S.,et al, 1998
Serotonin Syndrome and the Combined Use of Deprenyl and An Antidepressant in Parkinson's Disease
Neurol 48:1070-1077, Richard,I.H.,et al, 1997
Pharmacogenetics and Drug Metabolism of Newer Antidepressant Agents
J Clin Psychiatry 55:38-45, DeVane,C.L., 1994
Association of Coprescription of Triptan Antimigraine Drugs and Selective Serotonin Reuptake Inhibitor or Selective Norepinephrine Reuptake Inhibitor Antidepressants with Serotonin Syndrome
JAMA Neurol 75:566-572, Orlova, Y.,et al, 2018
Diabetic Sensory and Motor Neuropathy
NEJM 374:1455-1464, Vinik, A.I.,et al, 2016
Assessment and Management of Behavioral and Psychological Symptoms of Dementia
BMJ 350:h369, Kales, H.C.,et al, 2015
Fibromyalgia
BMJ 345:g1224, Rahman, A.,et al, 2014
Inhibition of Serotonin Reuptake by Antidepressants and Cerebral Microbleeds in the General Population
Stroke 45:1951-1957, Aarts, N.,et al, 2014
Disorders of the Nervous System Caused by Drugs, Toxins, and Chemical Agents, Serotonin Reuptake Inhibitors and Related Drugs
Adams & Victors Principles of Neurology Chp 43, pg 1212, Ropper, A.H.,et al, 2014
Disorders of the Nervous System Caused by Drugs, Toxins, and Chemical Agents, Lithium
Adams & Victors Principles of Neurology Chp 43, pg 1212, Ropper, A.H.,et al, 2014
A Randomized, Double-Blind, Placebo-Controlled Trial of Antidepressants in Parkinson Disease
Neurol 78:1229-1236, Richard,I.H.,et al, 2012
Pharmaceutical Interventions for Emotionalism After Stroke
Stroke 41:e460-e461, Hackett,M.L., et al, 2010
Facial Pain
The Neurologist 15:171-177, Graff-Radford,S.B., 2009
Narrative Review: Reversible Cerebral Vasoconstriction Syndromes
Ann Intern Med 146:34-44, Calabrese,L.H.,et al, 2007
Effects of Treatments for Symptoms of Painful Diabetic Neuropathy: Systematic Review
BMJ 335:87-90, Wong,M.-C.,et al, 2007
Duloxetine-induced Syndrome of Inappropriate Antidiuretic Hormone Secretion and Seizures
Neurol 66:773-774, Maramatton,B.V., 2006
Diffuse Cerebral Vasoconstriction (Call-Fleming Syndrome) and Stroke Associated with Antidepressants
Neurol 67:159-160, Noskin,O.,et al, 2006
Ten Most Commonly Asked Questions About the Psychiatric Aspects of Parkinson's Disease
The Neurologist 9:50-56, Reich,S.G. & Marsh,L., 2003
Tinnitus
NEJM 347:904-910, Lockwood,A.H.,et al, 2002
Acute Dystonia Induced by Drug Treatment
BMJ 319:623-626, vanHarten,P.N.,et al, 1999
Managing the Neuropsychiatric Symptoms of Parkinson's Disease
Neurol 50:S33-S38, Lieberman,A., 1998
A 55-Year-Old Man with Attention-Deficit/Hyperactivity Disorder
JAMA 280:1086-1092, Biederman,J., 1998
Clinical Features and Pharmacologic Treatment of Behavioral Symptoms of Alzheimer's Disease
Neurol 48 (Suppl 6) :S17-S24997., Borson,S.&Raskind,M.A., 1997
A Survey of Antidepressant Drug Use in Parkinson's Disease
Neurol 49:1168-1170, Richard,I.H.,et al, 1997
Postherpetic Neuralgia-Pathogenesis, Treatment and Prevention
NEJM 335:32-42, Kost,R.G.&Straus,S.E., 1996
A Depressed Workman with Heatstroke
Lancet 347:1016, Albukrek,D.,et al, 1996
Management of the Behavioral Manifestations of Dementia
Arch Int Med 155:250-260, Yeager,B.F.,et al, 1995
Neuropathic Pain of Peripheral Origin:Advances in Pharmacologic Treatment
Neurol 45 (suppl 8) :s17-s25995., Galer,B.S., 1995
Anticonvulsant Effect of Fluoxetine in Humans
Neurol 45:1926-1927, Favale,E.,et al, 1995
Painful Polyneuropathy:Diagnosis, Pathophysiology, and Management
Semin Neurol 14:237-246, Galer,B.S., 1994
Increase of Parkinson Disability after Fluoxetine Medication
Neurol 43:211-213, Steur,E.N.H.J., 1993
Psychotropic Drugs and Sleep
BMJ 306:1331-1334, Eisen,J.,et al, 1993
Toxic Reaction Following the Combined Administration of Fluoxetine and Phenytoin:Two Case Reports
JNNP 55:412-413, Jalil,P., 1992